IP Library › Granted Patent US 10,335,131
Granted Patent B2
US 10,335,131 · App. 11/877,386 · Granted Jul 2, 2019

Methods for preventing tissue migration

Inventors: Vahid Saadat (Saratoga, CA); Ruey-Feng Peh (Mountain View, CA); Edmund A. Tam (Montara, CA); Chris A. Rothe (San Mateo, CA)
Assignee: INTUITIVE SURGICAL OPERATIONS, INC.
A61B17/02A61B1/00089A61B1/3137A61B17/3439A61B1/005A61B6/503A61B8/0883A61B2017/0237
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,335,131
App. No.
11/877,386
Granted
Jul 2, 2019
Kind
B2
Abstract

A method of inhibiting tissue migration comprises positioning an open area of a hood against or adjacent to a tissue region. The method also comprises displacing an opaque fluid with a transparent fluid from the open area. The method includes engaging a portion of the tissue region within the open area via an end effector advanced through the open area and which grasps onto the portion. The end effector includes a tapered section, tapered along its entire length, through which a lumen extends. The tapered section includes threads extending from a surface of the tapered section in a direction orthogonal to the longitudinal axis. The tissue region is pierced while displacing the opaque fluid with the transparent fluid through the distal opening of the hood and while maintaining engagement of the portion of the tissue region such that distal movement of the tissue is inhibited.

Claims (8)

1. A method of inhibiting tissue migration during a procedure, comprising: positioning an open area of a non-inflatable hood against or adjacent to a tissue region, where the hood expands when unconstrained to a deployed configuration which defines the open area; displacing an opaque fluid with a transparent fluid from the open area through a distal opening in the hood defined by the hood and the tissue region; engaging a portion of the tissue region within the open area via an end effector advanced through the open area and which grasps onto the portion, the end effector including a tapered section through which a lumen extends, the tapered section being tapered along its entire length, the tapered section being tapered along a longitudinal axis of the end effector and including threads extending from a surface of the tapered section in a direction orthogonal to the longitudinal axis, wherein engaging comprises screwing the tapered and threaded section of the end effector into the portion of tissue region; and piercing the tissue region while displacing the opaque fluid with the transparent fluid through the distal opening of the hood and while maintaining engagement of the portion of the tissue region such that distal movement of the tissue is inhibited.

2. The method of claim 1 wherein piercing comprises piercing into or through an atrial septum towards a left atrial chamber.

3. The method of claim 1 wherein piercing comprises inserting a needle through the tissue region until an adjacent body lumen is entered by the needle.

4. The method of claim 1 further comprising directly visualizing the engaging and piercing of the tissue region within the open area.

5. The method of claim 1 further comprising visualizing a position of the non-inflatable hood with respect to the tissue region via a plurality of radiopaque elements positioned along the non-inflatable hood prior to piercing the tissue region.

6. The method of claim 1 further comprising advancing a flexible member having a radiopaque distal end within the open area such that the radiopaque distal end contacts the tissue region prior to piercing the tissue region.

7. A method of inhibiting tissue migration during a procedure, comprising: expanding a non-inflatable hood to a deployed configuration which defines an open area, the hood including a distal edge; positioning the distal edge of the hood adjacent to a tissue region; extending a counter-traction device through the open area and into engagement with the tissue region; deploying a piercing instrument through the open area and into the tissue region while the counter-traction device maintains engagement with the tissue region such that distal movement of the tissue region is inhibited, wherein the counter-traction device includes an end effector with threads extending from a tapered surface in a direction orthogonal to a longitudinal axis of the end effector, the tapered surface being tapered along its entire length, wherein the tapered surface is tapered along the longitudinal axis, and wherein extending the counter-traction device into engagement with the tissue region includes threading the tapered surface of the end effector into the tissue region; and flushing a transparent fluid through the open area and distally beyond the distal edge of the hood while the piercing instrument is deployed into the tissue region.

8. The method of claim 7 wherein deploying the piercing instrument includes extending the piercing instrument through a side opening in the tapered surface.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2013
From: TRIPLEPOINT CAPITAL LLC
To: VOYAGE MEDICAL, INC.
Reel/Frame 031029/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2013
From: VOYAGE MEDICAL, INC.
To: INTUITIVE SURGICAL OPERATIONS, INC.
Reel/Frame 031030/0061 →
SECURITY AGREEMENT Recorded Sep 24, 2012
From: VOYAGE MEDICAL, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 029011/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2008
From: ROTHE, CHRIS A.; SAADAT, VAHID; PEH, RUEY-FENG; TAM, EDMUND
To: VOYAGE MEDICAL, INC.
Reel/Frame 020801/0498 →
Continuity (2)
Provisional Application 60862575 · Oct 23, 2006
Related Publication 20080214889A1 · Sep 4, 2008